Care for Patients with Type 2 Diabetes in a Random Sample of Community Family Practices in Ontario, Canada

Table 6

Screening for and management of risk factors.

Clinical activity	Value	Median, SD, range	ICC
		(where applicable)
BP result documented, %	98
No. of BP readings	15	15, 9, 0–24	0.06424 (0.042231, 0.086249)
Mean BP;
Systolic mmHg	134	135, 12, 102–165	−0.14068 (−0.187383, −0.093977)
Within systolic BP targets of ≤130	31.0		0.00 (−0.003311, 0.003311)
Diastolic, mmHg	74	74, 7, 54–94	0.03471 (0.020974, 0.048446)
Within diastolic BP targets of ≤80	84.5		0.00 (−0.003311, 0.003311)
Lipid profile obtained once, %	97		0.040813 (0.025322, 0.056304)
Mean total cholesterol	4.58	4.49, 0.99, 2.43–7.98	−0.06611 (−0.084751, −0.047469)
Medications to prevent complications	% Patients
On ACE I	40.0		−0.02382 (−0.028101, −0.019539)
On lipid lowering medications	39.2		0.38283 (0.306461, 0.459199)
On ASA	22.7		0.045959 (0.029007, 0.062911)